Wordt geladen...
Biomarker predictors for immunotherapy benefit in breast: beyond PD-L1
PURPOSE OF REVIEW: Immune checkpoint blockade (ICB) has changed the clinical course of multiple cancer types and durable responses have now been observed in breast cancer (BC) patients. Most data suggest that, compared to other subtypes, triple-negative BC (TNBC) patients are more responsive to ICB,...
Bewaard in:
| Gepubliceerd in: | Curr Breast Cancer Rep |
|---|---|
| Hoofdauteurs: | , |
| Formaat: | Artigo |
| Taal: | Inglês |
| Gepubliceerd in: |
2019
|
| Onderwerpen: | |
| Online toegang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7731906/ https://ncbi.nlm.nih.gov/pubmed/33312343 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s12609-019-00331-5 |
| Tags: |
Voeg label toe
Geen labels, Wees de eerste die dit record labelt!
|